Growth Metrics

Ekso Bionics Holdings (EKSO) Gross Profit (2016 - 2026)

Ekso Bionics Holdings has reported Gross Profit over the past 14 years, most recently at $1.7 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 38.43% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 28.03% decrease, with the full-year FY2025 number at $6.8 million, down 28.03% from a year prior.
  • Gross Profit reached $1.7 million in Q4 2025 per EKSO's latest filing, down from $2.5 million in the prior quarter.
  • The five-year high for Gross Profit was $2.7 million in Q4 2024, with the low at $819000.0 in Q2 2025.
  • The 5-year median for Gross Profit is $1.9 million (2021), against an average of $1.9 million.
  • Peak YoY movement for Gross Profit: surged 93.88% in 2021, then crashed 68.94% in 2025.
  • Tracing EKSO's Gross Profit over 5 years: stood at $2.4 million in 2021, then tumbled by 30.52% to $1.7 million in 2022, then skyrocketed by 41.18% to $2.4 million in 2023, then rose by 14.56% to $2.7 million in 2024, then crashed by 38.43% to $1.7 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $1.7 million, $2.5 million, and $819000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.